Vascular BioSciences to Present at NHLBI Innovation Conference

Online, June 5, 2013 (Newswire.com) - Vascular BioSciences (VBS) announces it will be presenting at a National Heart Lung and Blood Institute (NHLBI) conference on June 11, 2013, from 10:30 to 5pm at the Janssen Research & Development Labs, 3210 Merryfield Row, San Diego CA 92130.

This conference will bring together small businesses, angel investors, venture capitalists, strategic partners, and business leaders from the biotech and pharmaceutical industries. The conference is intended to provide a valuable opportunity for companies to present their technology and network with potential investors and partners. The conference will feature presentations by top National Heart Lung and BIood funded companies with innovative technologies on the brink of commercialization, an expert panel of investors, and opportunities for partnering and networking. Vascular BioScience will give a fifteen-minute platform presentation as well as a poster presentation during the conference. The poster and presentation will provide an overview on the potential and uses for the CAR peptide in the health and medical industry.

VBS CEO David Mann commented, "Having received several NHLBI grants for our research, it is a further honor to be selected as a presenting company at next Tuesday's conference. We look forward to sharing the story of our CAR peptide and its potential."

About Vascular BioSciences

Vascular BioSciences, a diversified biomedical company with operations in California and North Carolina, provides disease solutions in order to enhance and prolong human life.

Vascular BioSciences makes interventional catheters to obtain endoarterial biopsies, provides molecular diagnostic services, and through its majority owned subsidiary VBS Pharmaceuticals, develops targeted therapeutics for patients with difficult-to-treat diseases.

More information is available at www.vascularbiosciences.com and www.vbspharma.com.